We confirmed that FAK phosphorylation on S910 residue was repeatedly impaired in the different KI-treated ovarian cancer cell lines analysed (Fig. 3e,f; for the original blots, please see Supplementary Fig. 8B), consistent with the reduced cell migration we observed upon MAP3K8 inhibition (Fig. 2c). This evidence concerns the gene PTK2 and ovarian cancer.